Post-occlusion administration of sodium butyrate attenuates cognitive impairment in a rat model of chronic cerebral hypoperfusion

Pharmacology Biochemistry and Behavior

Volumn 135, Issue , 2015, Pages 53-59

  Liu, Hui ^b   Zhang, Jun Jian ^a   Li, Xiong ^b   Yang, Ying ^b   Xie, Xiao Feng ^b   Hu, Ke ^b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Hubei Clinical Research Center for Dementia and Cognitive Impairment   (China)

Author keywords

Chronic cerebral hypoperfusion; Cognitive impairment; Histone acetylation; NF E2 related factor 2; Sodium butyrate

Indexed keywords

BUTYRIC ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE H4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR NRF2; HDAC1 PROTEIN, RAT; HDAC2 PROTEIN, RAT; HISTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; CHRONIC CEREBRAL HYPOPERFUSION; COGNITION; COGNITIVE DEFECT; COMMON CAROTID ARTERY; DISABILITY; ENZYME INHIBITION; HIPPOCAMPUS; HISTONE ACETYLATION; LEARNING; MALE; MEMORY; MENTAL PERFORMANCE; NEUROPROTECTION; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; RAT; RAT MODEL; SPATIAL LEARNING; TREATMENT DURATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BRAIN ISCHEMIA; COGNITION DISORDERS; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; MAZE TEST; METABOLISM; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; RECOGNITION; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; BRAIN ISCHEMIA; BUTYRIC ACID; CAROTID STENOSIS; COGNITION DISORDERS; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONES; INJECTIONS, INTRAPERITONEAL; MALE; MAZE LEARNING; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; RECOGNITION (PSYCHOLOGY);

EID: 84930683260     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2015.05.012     Document Type: Article

References (31)

1. J.E. Bolden, M.J. Peart, and R.W. Johnstone Anticancer activities of histone deacetylase inhibitors Nat Rev Drug Discov 5 2006 769 784
2. M.J. Calkins, R.J. Jakel, D.A. Johnson, K. Chan, Y.W. Kan, and J.A. Johnson Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription Proc Natl Acad Sci U S A 102 2005 244 249
3. M.J. Calkins, D.A. Johnson, J.A. Townsend, M.R. Vargas, J.A. Dowell, and T.P. Williamson The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease Antioxid Redox Signal 11 2009 497 508
4. S.Y. Chen, and N.L. Sang Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors J Biomed Biotechnol 2011 2011 Article ID 197946. http://dx.doi.org/10.1155/2011/197946
5. P. De Rango, V. Caso, D. Leys, M. Paciaroni, M. Lenti, and P. Cao The role of carotid artery stenting and carotid endarterectomy in cognitive performance: a systematic review Stroke 39 2008 3116 3127
6. E. Farkas, P.G.M. Luiten, and F. Bari Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases Brain Res Rev 54 2007 162 180
7. A. Fischer, F. Sananbenesi, X.Y. Wang, M. Dobbin, and L.H. Tsai Recovery of learning and memory is associated with chromatin remodelling Nature 447 2007 [178-U2]
8. A. Fischer, F. Sananbenesi, A. Mungenast, and L.H. Tsai Targeting the correct HDAC(s) to treat cognitive disorders Trends Pharmacol Sci 31 2010 605 617
9. J. Graff, and L.H. Tsai The potential of HDAC inhibitors as cognitive enhancers Annu Rev Pharmacol 53 2013 311 330
10. J.S. Guan, S.J. Haggarty, E. Giacometti, J.H. Dannenberg, N. Joseph, and J. Gao HDAC2 negatively regulates memory formation and synaptic plasticity Nature 459 2009 55-U8
11. C. Iadecola The pathobiology of vascular dementia Neuron 80 2013 844 866
12. M. Kilgore, C.A. Miller, D.M. Fass, K.M. Hennig, S.J. Haggarty, and J.D. Sweatt Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease Neuropsychopharmacology 35 2010 870 880
13. H.J. Kim, M. Rowe, M. Ren, J.S. Hong, P.S. Chen, and D.M. Chuang Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action J Pharmacol Exp Ther 321 2007 892 901
14. E. Korzus, M.G. Rosenfeld, and M. Mayford CBP histone acetyltransferase activity is a critical component of memory consolidation Neuron 42 2004 961 972
15. H. Liu, and J.J. Zhang Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress Int J Neurosci 122 2012 494 499
16. H. Liu, J.J. Zhang, Y. Yang, L. Zhang, and X.X. Zeng Decreased cerebral perfusion and oxidative stress result in acute and delayed cognitive impairment Curr Neurovasc Res 9 2012 152 158
17. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method Methods 25 2001 402 408
18. P.A. Marks, V.M. Richon, T. Miller, and W.K. Kelly Histone deacetylase inhibitors Adv Cancer Res 91 2004 137 168
19. A. Osawa, S. Maeshima, Y. Shimamoto, E. Maeshima, E. Sekiguchi, and K. Kakishita Relationship between cognitive function and regional cerebral blood flow in different types of dementia Disabil Rehabil 26 2004 739 745
20. S. Peleg, F. Sananbenesi, A. Zovoilis, S. Burkhardt, S. Bahari-Javan, and R.C. Agis-Balboa Altered histone acetylation is associated with age-dependent memory impairment in mice Science 328 2010 753 756
21. P. Rane, J. Shields, M. Heffernan, Y. Guo, S. Akbarian, and J.A. King The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD Neuropharmacology 62 2012 2409 2412
22. A. Ricobaraza, M. Cuadrado-Tejedor, A. Perez-Mediavilla, D. Frechilla, J. Del Rio, and A. Garcia-Osta Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model Neuropsychopharmacology 34 2009 1721 1732
23. T. Satoh, K. Kosaka, K. Itoh, A. Kobayashi, M. Yamamoto, and Y. Shimojo Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1 J Neurochem 104 2008 1116 1131
24. B. Sharma, and N. Singh Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats Psychopharmacology (Berl) 215 2011 677 687
25. H. Sun, J. Zhang, L. Zhang, H. Liu, H. Zhu, and Y. Yang Environmental enrichment influences BDNF and NR1 levels in the hippocampus and restores cognitive impairment in chronic cerebral hypoperfused rats Curr Neurovasc Res 7 2010 268 280
26. C.G. Vecsey, J.D. Hawk, K.M. Lattal, J.M. Stein, S.A. Fabian, and M.A. Attner Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation J Neurosci 27 2007 6128 6140
27. B. Wang, X. Zhu, Y. Kim, J. Li, S. Huang, and S. Saleem Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage Free Radic Biol Med 52 2012 928 936
28. Y. Xu, J.J. Zhang, L. Xiong, L. Zhang, D. Sun, and H. Liu Green tea polyphenols inhibit cognitive impairment induced by chronic cerebral hypoperfusion via modulating oxidative stress J Nutr Biochem 21 2010 741 748
29. Y. Yang, J. Zhang, H. Liu, and L. Zhang Change of Nrf2 expression in rat hippocampus in a model of chronic cerebral hypoperfusion Int J Neurosci 124 2014 577 584
30. S.H. Yeh, C.H. Lin, and P.W. Gean Acetylation of nuclear factor-kappaB in rat amygdala improves long-term but not short-term retention of fear memory Mol Pharmacol 65 2004 1286 1292
31. H. Zhu, J. Zhang, H. Sun, L. Zhang, H. Liu, and X. Zeng An enriched environment reverses the synaptic plasticity deficit induced by chronic cerebral hypoperfusion Neurosci Lett 502 2011 71 75